249 studies found for:    cardiac CT OR CAT scan OR coronary artery scan | Open Studies | NIH, U.S. Fed
Show Display Options
RSS Create an RSS feed from your search for:
cardiac CT OR CAT scan OR coronary artery scan | Open Studies | NIH, U.S. Fed
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung Cancer
Conditions: Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer
Interventions: Radiation: External Beam Radiation Therapy;   Radiation: Image-Guided Adaptive Radiation Therapy;   Drug: Paclitaxel;   Drug: Carboplatin;   Radiation: Fludeoxyglucose F-18;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Other: Laboratory Biomarker Analysis
2 Recruiting Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery
Conditions: Gastrin-Producing Neuroendocrine Tumor;   Pancreatic Glucagonoma;   Pancreatic Insulinoma;   Pancreatic Polypeptide Tumor;   Recurrent Pancreatic Neuroendocrine Carcinoma;   Somatostatin-Producing Neuroendocrine Tumor
Interventions: Biological: Ziv-Aflibercept;   Radiation: Computed Tomography Perfusion Imaging;   Other: Laboratory Biomarker Analysis
3 Unknown  The Addition of Cardiac CT to Exercise Treadmill Testing in the Evaluation of Angina
Condition: Angina
Intervention:
4 Recruiting Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer
Conditions: Clear Cell Renal Cell Carcinoma;   Stage IV Renal Cell Cancer
Interventions: Drug: Entinostat;   Biological: Aldesleukin;   Other: Pharmacological Study;   Other: Laboratory Biomarker Analysis;   Radiation: Fludeoxyglucose F-18;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography
5 Recruiting Dual Energy Computed Tomography (CT) in Finding Bone Metastases in Patients With Cancer
Conditions: Malignant Neoplasm;   Metastatic Malignant Neoplasm to the Bone
Interventions: Radiation: virtual non-calcium dual-energy computed tomography;   Radiation: computed tomography
6 Not yet recruiting FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia
Condition: Untreated Adult Acute Myeloid Leukemia
Interventions: Drug: Chemotherapy;   Drug: Cytarabine;   Other: Fluorothymidine F-18;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Other: Laboratory Biomarker Analysis
7 Not yet recruiting FES PET/CT in Predicting Response in Patients With Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
Conditions: Estrogen Receptor Positive;   HER2/Neu Negative;   Progesterone Receptor Negative;   Progesterone Receptor Positive;   Stage IV Breast Cancer
Interventions: Radiation: F-18 16 Alpha-Fluoroestradiol;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Other: Laboratory Biomarker Analysis
8 Recruiting Computed Tomography and Biomarker Analysis in Diagnosing Coronary Artery Disease in Asymptomatic Patients Who Have Undergone Stem Cell Transplant
Conditions: Cancer Survivor;   Diabetes Mellitus;   Hypertension
Interventions: Procedure: computed tomography;   Other: cytology specimen collection procedure;   Other: laboratory biomarker analysis;   Other: questionnaire administration
9 Recruiting Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer
Conditions: Recurrent Thyroid Gland Carcinoma;   Stage IVA Thyroid Gland Follicular Carcinoma;   Stage IVA Thyroid Gland Papillary Carcinoma;   Stage IVB Thyroid Gland Follicular Carcinoma;   Stage IVB Thyroid Gland Papillary Carcinoma;   Stage IVC Thyroid Gland Follicular Carcinoma;   Stage IVC Thyroid Gland Papillary Carcinoma
Interventions: Radiation: Iodine I 124;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Drug: Trametinib;   Radiation: Iodine I-131;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
10 Recruiting Dual Energy CT for Ischemia Determination Compared to "Gold Standard" Non-Invasive and Invasive Techniques
Condition: Ischemia
Intervention: Procedure: CT and stress test
11 Not yet recruiting 18F-FES PET/CT in Imaging Patients With Desmoid Tumors
Conditions: Deep Fibromatosis/Desmoid Tumor;   Familial Adenomatous Polyposis
Interventions: Radiation: F-18 16 Alpha-Fluoroestradiol;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Other: Laboratory Biomarker Analysis
12 Recruiting 18F-FLT PET/CT in Measuring Cell Proliferation in Patients With Brain Tumors
Conditions: Malignant Primary Brain Neoplasm;   Metastatic Malignant Neoplasm to the Brain;   Recurrent Adult Brain Neoplasm
Interventions: Radiation: Fluorothymidine F-18;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography
13 Recruiting 18F-DOPA-PET in Planning Surgery in Patients With Gliomas
Conditions: Acoustic Schwannoma;   Adult Anaplastic (Malignant) Meningioma;   Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Anaplastic Oligodendroglioma;   Adult Brain Stem Glioma;   Adult Choroid Plexus Neoplasm;   Adult Craniopharyngioma;   Adult Diffuse Astrocytoma;   Adult Ependymoblastoma;   Adult Ependymoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Grade I Meningioma;   Adult Grade II Meningioma;   Adult Medulloblastoma;   Adult Mixed Glioma;   Adult Myxopapillary Ependymoma;   Adult Oligodendroglioma;   Adult Papillary Meningioma;   Adult Pilocytic Astrocytoma;   Adult Pineal Gland Astrocytoma;   Adult Pineoblastoma;   Adult Pineocytoma;   Adult Primary Melanocytic Lesion of Meninges;   Adult Subependymal Giant Cell Astrocytoma;   Adult Subependymoma;   Childhood Cerebellar Anaplastic Astrocytoma;   Childhood Cerebellar Astrocytoma;   Childhood Cerebral Anaplastic Astrocytoma;   Childhood Cerebral Astrocytoma;   Childhood Choroid Plexus Neoplasm;   Childhood Craniopharyngioma;   Childhood Ependymoblastoma;   Childhood Grade I Meningioma;   Childhood Grade II Meningioma;   Childhood Grade III Meningioma;   Childhood Infratentorial Ependymoma;   Childhood Mixed Glioma;   Childhood Supratentorial Ependymoma;   Malignant Adult Intracranial Hemangiopericytoma;   Medulloepithelioma;   Newly Diagnosed Childhood Ependymoma;   Recurrent Adult Brain Neoplasm;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Cerebellar Astrocytoma;   Recurrent Childhood Cerebral Astrocytoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Fibrillary Astrocytoma;   Recurrent Childhood Gemistocytic Astrocytoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Oligoastrocytoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Pilocytic Astrocytoma;   Recurrent Childhood Pilomyxoid Astrocytoma;   Recurrent Childhood Pineoblastoma;   Recurrent Childhood Pleomorphic Xanthoastrocytoma;   Recurrent Childhood Protoplasmic Astrocytoma;   Recurrent Childhood Subependymal Giant Cell Astrocytoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor;   Recurrent Childhood Visual Pathway Glioma;   Untreated Childhood Anaplastic Astrocytoma;   Untreated Childhood Anaplastic Oligoastrocytoma;   Untreated Childhood Anaplastic Oligodendroglioma;   Untreated Childhood Brain Stem Glioma;   Untreated Childhood Diffuse Astrocytoma;   Untreated Childhood Fibrillary Astrocytoma;   Untreated Childhood Gemistocytic Astrocytoma;   Untreated Childhood Giant Cell Glioblastoma;   Untreated Childhood Glioblastoma;   Untreated Childhood Gliomatosis Cerebri;   Untreated Childhood Gliosarcoma;   Untreated Childhood Medulloblastoma;   Untreated Childhood Oligoastrocytoma;   Untreated Childhood Oligodendroglioma;   Untreated Childhood Pilocytic Astrocytoma;   Untreated Childhood Pilomyxoid Astrocytoma;   Untreated Childhood Pineoblastoma;   Untreated Childhood Pleomorphic Xanthoastrocytoma;   Untreated Childhood Protoplasmic Astrocytoma;   Untreated Childhood Subependymal Giant Cell Astrocytoma;   Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor;   Untreated Childhood Visual Pathway Glioma
Interventions: Drug: Fluorine F 18 Fluorodopa;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Procedure: Diffusion Weighted Imaging;   Procedure: Perfusion Magnetic Resonance Imaging;   Procedure: Therapeutic Conventional Surgery;   Procedure: Biopsy;   Other: Laboratory Biomarker Analysis
14 Recruiting PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer
Conditions: Recurrent Non-Small Cell Lung Carcinoma;   Stage IIA Non-Small Cell Lung Carcinoma;   Stage IIB Non-Small Cell Lung Carcinoma;   Stage IIIA Non-Small Cell Lung Cancer;   Stage IIIB Non-Small Cell Lung Cancer;   Stage IV Non-Small Cell Lung Cancer
Interventions: Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Radiation: Intensity-Modulated Radiation Therapy;   Radiation: Proton Beam Radiation Therapy;   Drug: Carboplatin;   Drug: Paclitaxel
15 Recruiting 18F-DOPA-PET in Finding Tumors in Patients With Newly Diagnosed Gliomas Undergoing Radiation Therapy
Conditions: Adult Anaplastic (Malignant) Meningioma;   Adult Anaplastic Astrocytoma;   Adult Anaplastic Ependymoma;   Adult Brain Stem Glioma;   Adult Choroid Plexus Neoplasm;   Adult Ependymoblastoma;   Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma;   Adult Medulloblastoma;   Adult Mixed Glioma;   Adult Papillary Meningioma;   Adult Pineal Gland Astrocytoma;   Adult Pineoblastoma;   Adult Primary Melanocytic Lesion of Meninges;   Adult Supratentorial Primitive Neuroectodermal Tumor
Interventions: Drug: Fluorine F 18 Fluorodopa;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Procedure: Perfusion Magnetic Resonance Imaging;   Procedure: Diffusion Weighted Imaging;   Radiation: Intensity-Modulated Radiation Therapy;   Drug: Temozolomide;   Other: Quality-of-Life Assessment
16 Not yet recruiting Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer
Conditions: Recurrent Hypopharyngeal Squamous Cell Carcinoma;   Recurrent Laryngeal Squamous Cell Carcinoma;   Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma;   Recurrent Oral Cavity Squamous Cell Carcinoma;   Recurrent Oropharyngeal Squamous Cell Carcinoma;   Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma;   Stage III Hypopharyngeal Squamous Cell Carcinoma;   Stage III Laryngeal Squamous Cell Carcinoma;   Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma;   Stage III Nasopharyngeal Keratinizing Squamous Cell Carcinoma;   Stage III Oral Cavity Squamous Cell Carcinoma;   Stage III Oropharyngeal Squamous Cell Carcinoma;   Stage IVA Hypopharyngeal Squamous Cell Carcinoma;   Stage IVA Laryngeal Squamous Cell Carcinoma;   Stage IVA Nasopharyngeal Keratinizing Squamous Cell Carcinoma;   Stage IVA Oral Cavity Squamous Cell Carcinoma;   Stage IVA Oropharyngeal Squamous Cell Carcinoma;   Stage IVB Hypopharyngeal Squamous Cell Carcinoma;   Stage IVB Laryngeal Squamous Cell Carcinoma;   Stage IVB Nasopharyngeal Keratinizing Squamous Cell Carcinoma;   Stage IVB Oral Cavity Squamous Cell Carcinoma;   Stage IVB Oropharyngeal Squamous Cell Carcinoma;   Stage IVC Hypopharyngeal Squamous Cell Carcinoma;   Stage IVC Laryngeal Squamous Cell Carcinoma;   Stage IVC Nasopharyngeal Keratinizing Squamous Cell Carcinoma;   Stage IVC Oral Cavity Squamous Cell Carcinoma;   Stage IVC Oropharyngeal Squamous Cell Carcinoma
Interventions: Radiation: Stereotactic Body Radiation Therapy;   Procedure: Positron Emission Tomography;   Procedure: Computed Tomography;   Other: Quality-of-Life Assessment
17 Recruiting Fluorine F 18 Sodium Fluoride PET/CT and Whole Body and Axial MRI in Finding Metastases in Patients With Recurrent Prostate Cancer
Condition: Recurrent Prostate Cancer
Interventions: Procedure: computed tomography;   Procedure: bone scan;   Procedure: 3-Tesla magnetic resonance imaging;   Procedure: diffusion-weighted magnetic resonance imaging;   Radiation: fluorine F 18 sodium fluoride;   Procedure: positron emission tomography;   Other: laboratory biomarker analysis
18 Recruiting Screening for Age-Related Skeletal Muscle Dysfunction
Condition: Sarcopenia
Interventions: Radiation: DXA scanning;   Radiation: CT imaging
19 Recruiting Gallium Ga 68-Edotreotide PET/CT Compared With Indium In 111 Pentetreotide Plus Contrast-Enhanced CT (or MRI) in Diagnosing Patients With Neuroendocrine Tumors and Other Somatostatin Receptor Positive Tumors
Conditions: Adult Medulloblastoma;   Childhood Medulloblastoma;   Neuroblastoma;   Neuroendocrine Tumor;   Somatostatinoma
Interventions: Radiation: gallium Ga 68-edotreotide;   Procedure: positron emission tomography/computed tomography;   Radiation: indium In 111 pentetreotide;   Procedure: computed tomography;   Procedure: contrast-enhanced magnetic resonance imaging
20 Recruiting High Risk Endometrial Cancer and Lymph Nodes Metastasis
Condition: Gynecologic Cancer
Interventions: Procedure: PET/CT Scan;   Procedure: Sentinel Lymph Node Mapping

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years